Med-tech firms raising money in public or private financings, including: Emergent Biosolutions, Medx Health, Veracyte.

New hires and promotions in the med-tech industry, including: Corvent Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Axsome, Diurnal, Pharmacyte, Revive.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adicet, Aerpio, Alvotech, Celularity, Cohbar, Evotec, Genfit, IMV, Recursion, Regeneron, Scholar Rock, Secarna, Specifica, SRI, Teva, Therapeutics Solutions, Torii, VBI, Verrica, Viacyte, Vyripharm.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Axcella, Biontech, Clovis, Cytodyn, Elios, Emmaus, Fosun, Hepion, KBP, Modag, Novavax, Palatin, Pfizer.

Biopharmas raising money in public or private financings, including: Adaptive Phage, ARC, Emerald, Emergent, Gentibio, Immunic, Myovant, Nicox, Qualigen, Taysha, Tiziana.

Quarterly snapshots from biopharma companies with marketed products, including: Acorda, Biomarin, Horizon, Jazz, Regeneron, Rigel.

New hires and promotions in the biopharma industry, including: Affimed, Akouos, CN Bio, Meiragtx, Rapt, Redx, Ribometrix, Silicon.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Apogenix, Ascletis, Aytu Bioscience, Calidi, Celltrion, Direct Biologics, Edesa, Eisai, Merck, Foresee, Hutchison China Meditech, Poxel, Sumitomo Dainippon, Realta Life Sciences, Relief, Neurorx, Revive, Sound, Takeda, Teva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AI, Ampio, Ascentage, Cerecor, Clarity, Cytodyn, Hutchison China Meditech, Immunic, Moderna, Opthea.